drugset / Trial / NCT01578330
A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720
NaSingle-groupOpen-labelSupportive care
Summary
The study will assess the patients' satisfaction of treatment after 12 months treatment with fingolimod It also will assess the tolerability profile of fingolimod in a small population.
Timeline
- Start
- 2012-10
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fingolimod | Small molecule | 0.5 mg | Oral |